Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Pharma
Sandoz inks dual settlements to resolve most US antitrust claims
Novartis’ generics and biosimilars spinout Sandoz is plotting its escape from ongoing U.S. litigation tied to alleged generic drug price-fixing.
Fraiser Kansteiner
Aug 3, 2026 10:18am
Novartis' Pluvicto unlocks substantial new patient pool
Aug 3, 2026 8:33am
After 3 CRLs, FDA approves Outlook's AMD drug Lytenava
Jul 27, 2026 11:51am
Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth
Jul 21, 2026 10:36am
Novartis reconnects to its past as it moves forward
Jul 20, 2026 8:00am
FDA grants full approval to Novartis' Fabhalta in IgAN
Jul 17, 2026 11:33am
